References
- Okazaki S, Sekizawa A, Purwosunu Y, et al. Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. J Med Genet 2006;43:e47
- Whitehead CL, Walker SP, Ye L, et al. Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction. J Clin Endocrinol Metab 2013;98:E429–36
- Galbiati S, Inversetti A, Causarano V, et al. HIF1A and MIF as potential predictive mRNA biomarkers of pre-eclampsia: a longitudinal prospective study in high risk population. Clin Chem Lab Med 2015;53:1339–47
- Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005;25:258–64
- Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009;374:979–88
- Purwosunu Y, Sekizawa A. Okazaki, et al. Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma. Am J Obstet Gynecol 2009;200:386.e1–7
- Paiva P, Whitehead C, Saglam B, et al. Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia. J Clin Endocrinol Metab 2011;96:E1807–15
- Zumbrunn J, Trueb B. Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 1997;398:187–92
- Cocchia M, Huber R, Pantano S, et al. PLAC1, an Xq26 gene with placenta-specific expression. Genomics 2000;68:305–12
- Shanley DK, Kiely PA, Golla K, et al. Pregnancy-specific glycoproteins bind integrin αIIbβ3 and inhibit the platelet-fibrinogen interaction. PLoS One 2013;8:e57491